Molecure (WAR:MOC) Total Liabilities: zł7.73 Mil (As of Sep. 2025)


WAR:MOC Molecure SA WAR:MOC
29 GF Score
Price zł6.04
! 3 Warning Signs
View Full Analysis

What is Molecure Total Liabilities?

Molecure WAR:MOC +3.78% 29 Total Liabilities is zł7.73 Mil as of Sep. 2025. GuruFocus rates WAR:MOC with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Molecure's Total Liabilities for the quarter that ended in Sep. 2025 was zł7.73 Mil.

Molecure's quarterly Total Liabilities declined from Mar. 2025 (zł9.24 Mil) to Jun. 2025 (zł8.65 Mil) and declined from Jun. 2025 (zł8.65 Mil) to Sep. 2025 (zł7.73 Mil).

Molecure's annual Total Liabilities declined from Dec. 2022 (zł11.61 Mil) to Dec. 2023 (zł11.35 Mil) and declined from Dec. 2023 (zł11.35 Mil) to Dec. 2024 (zł10.31 Mil).

Molecure Total Liabilities Historical Data

* Premium members only.

The historical data trend for Molecure's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure Total Liabilities Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.10 10.45 11.61 11.35 10.31

Molecure Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.62 10.31 9.24 8.65 7.73
WAR:MOC
29GF Score
Molecure SA WAR:MOC
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecure Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Molecure's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.117+(5.051+0.104
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.042+0)
=10.31

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=113.721-103.408
=10.31

Molecure's Total Liabilities for the quarter that ended in Sep. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.053+(3.53+0.1
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.042+0)
=7.73

Total Liabilities=Total Assets (Q: Sep. 2025 )-Total Equity (Q: Sep. 2025 )
=97.151-89.426
=7.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of zł7.73 Mil mean?
Molecure (WAR:MOC) has a Total Liabilities of zł7.73 Mil as of Sep. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Molecure and its competitors.
Is Molecure's Total Liabilities too high?
Molecure's current Total Liabilities is zł7.73 Mil. Overall, Molecure has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Total Liabilities compare to VRTX and REGN?
Molecure's Total Liabilities of zł7.73 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Molecure and its competitors. Molecure's current Total Liabilities is zł7.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Total Liabilities of zł7.73 Mil. The current Total Liabilities is zł7.73 Mil. Molecure's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Total Liabilities is zł7.73 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecure Business Description

Other Exchanges 1B1:Germany
Address Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
29GF Score

Get the complete analysis for WAR:MOC

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł6.04
Price